Motor Evoked Potentials in Hereditary Spastic Paraplegia—A Systematic Review
Background: Hereditary Spastic Paraplegia (HSP) is a slowly progressive neurodegenerative disorder with no disease modifying treatment. Potential therapeutic approaches are emerging and large-scale clinical drug trials for patients with HSP are imminent. A sensitive biomarker to measure the drug eff...
Main Authors: | Sue-Faye Siow, Ruaridh Cameron Smail, Karl Ng, Kishore R. Kumar, Carolyn M. Sue |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-09-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fneur.2019.00967/full |
Similar Items
-
Reduced acetylated α-tubulin in SPAST hereditary spastic paraplegia patient PBMCs
by: Gautam Wali, et al.
Published: (2023-03-01) -
Outcome Measures and Biomarkers for Clinical Trials in Hereditary Spastic Paraplegia: A Scoping Review
by: Sue-Faye Siow, et al.
Published: (2023-09-01) -
Mitochondrial Function in Hereditary Spastic Paraplegia: Deficits in SPG7 but Not SPAST Patient-Derived Stem Cells
by: Gautam Wali, et al.
Published: (2020-08-01) -
Pharmacological rescue of mitochondrial and neuronal defects in SPG7 hereditary spastic paraplegia patient neurons using high throughput assays
by: Gautam Wali, et al.
Published: (2023-09-01) -
Oxidative Stress-Induced Axon Fragmentation Is a Consequence of Reduced Axonal Transport in Hereditary Spastic Paraplegia SPAST Patient Neurons
by: Gautam Wali, et al.
Published: (2020-05-01)